跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DIPHERELINE P.R. 3 mg Powder for Suspension for Injection - SFDA Drug Approval Details
Approvals
/
SFDA
/
DIPHERELINE P.R. 3 mg Powder for Suspension for Injection
Authorized
NCE
DIPHERELINE P.R. 3 mg Powder for Suspension for Injection
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
392bcec5635ab378
Company
Unknown
Type
NCE
Approval Details
Approval Id
392bcec5635ab378
Drug Approval Sfda Name
DIPHERELINE P.R. 3 mg Powder for Suspension for Injection
Trade Name
DIPHERELINE P.R. 3 mg Powder for Suspension for Injection
Generic Name
TRIPTORELIN
Register Number
1-686-17
Register Year
2021
Drug Type
NCE
Route Of Administration
Intramuscular use
Package Type
Vial
Package Size
1
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Restricted
Storage Conditions
do not store above 30°c
Shelf Life
36 Months
Distribution Site
Hospital
Description Code
7000001283-3-200000016487
Price
458.35
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
392bcec5635ab378
Type
NCE
Back to SFDA Approvals